Bioera Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.31 Cr
as on 23-12-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.90 Cr
as on 23-12-2024
- Revenue 28.72%
(FY 2021)
- Profit 59.66%
(FY 2021)
- Ebitda 28.06%
(FY 2021)
- Net Worth 6.71%
(FY 2021)
- Total Assets 11.25%
(FY 2021)
About Bioera Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.31 Cr.
The company currently has active open charges totaling ₹2.90 Cr.
Siddharth Salunke and Asha Salunke serve as directors at the Company.
- CIN/LLPIN
U24233PN2009PTC134193
- Company No.
134193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bioera Life Sciences Private Limited offer?
Bioera Life Sciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Diagnostic Medical Imaging Equipment, Diagnostic Imaging Accessories, Transilluminator, Laboratory Centrifuge, Laboratory Autoclave & Sterilizers, Class N Autoclave, Microcentrifuge, Gel Electrophoresis Equipment.
Who are the key members and board of directors at Bioera Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Salunke  | Director | 25-Jun-2009 | Current |
| Asha Salunke | Director | 25-Jun-2009 | Current |
Financial Performance of Bioera Life Sciences.
Bioera Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 28.72% increase. The company also saw a substantial improvement in profitability, with a 59.66% increase in profit. The company's net worth moved up by a moderate rise of 6.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioera Life Sciences?
In 2021, Bioera Life Sciences had a promoter holding of 91.46% and a public holding of 8.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioera Nutriments Private LimitedActive 10 months 19 daysSiddharth Salunke and Asha Salunke are mutual person
- Bioera Research &Development Private LimitedActive 12 years 8 months
Siddharth Salunke and Asha Salunke are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2021 | ₹0.97 M | Open |
Sidbi Creation Date: 01 Sep 2020 | ₹4.60 M | Open |
Bank Of Baroda (Gen Next Branch) Creation Date: 11 Oct 2012 | ₹4.00 M | Open |
How Many Employees Work at Bioera Life Sciences?
Bioera Life Sciences has a workforce of 22 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioera Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioera Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
